Cytek Biosciences, Inc. CTKB

Company Overview

Cytek Biosciences, Inc. is a life sciences technology company focused on the development and commercialization of advanced flow cytometry solutions used in biomedical research and clinical applications. The company operates within the life sciences research tools and diagnostics industry, serving academic institutions, pharmaceutical and biotechnology companies, and clinical research laboratories. Cytek’s core value proposition centers on enabling high-dimensional, high-sensitivity cellular analysis through differentiated optical and detector technologies.

The company’s primary revenue drivers are the sale of flow cytometry instruments, associated consumables, reagents, and recurring service and support contracts. Cytek is best known for its full-spectrum flow cytometry platforms, which are positioned as alternatives to conventional cytometry by capturing the complete spectral signature of fluorophores. Founded in 2014, Cytek commercialized its first major platform in the late 2010s and became a publicly traded company in 2021, using its IPO to expand global operations and invest in product development.